Abstract
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19) pandemic has affected millions of people worldwide. The pathophysiology of this virus is not very clearly known, thus, enormous efforts are being made by the scientific community to delineate its evading mechanism. In this review, we have summarized the hyperinflammation and humoral and cell-mediated immune response generated in human body after infection with the SARS-CoV-2 virus. The inflammatory response generated after infection by increased proinflammatory cytokines and chemokines, and complement proteins activation may likely contribute to disease severity. We also discussed the other factors that may affect immunity and could be important comorbidities in the disease severity and outcome.
References
1.
Andersen
KG
, Rambaut
A
, Lipkin
WI
, Holmes
EC
, Garry
RF
. The proximal origin of SARS-CoV-2
. Nat Med
. 2020 Apr
;26
(4
):450
–2
. .2.
Wu
F
, Zhao
S
, Yu
B
, Chen
YM
, Wang
W
, Song
ZG
, et al. A new coronavirus associated with human respiratory disease in China
. Nature
. 2020 Mar
;579
(7798
):265
–9
. .3.
Yan
R
, Zhang
Y
, Li
Y
, Xia
L
, Guo
Y
, Zhou
Q
. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
. Science
. 2020 Mar 27
;367
(6485
):1444
–8
. .4.
Lokugamage
KG
, Hage
A
, Schindewolf
C
, Rajsbaum
R
, Menachery
VD
. SARS-CoV-2 sensitive to type I interferon pretreatment
. BioRxiv
. 2020
.5.
Mantlo
E
, Bukreyeva
N
, Maruyama
J
, Paessler
S
, Huang
C
. Antiviral activities of type I interferons to SARS-CoV-2 infection
. Antiviral Res
. 2020 Apr 29
;179
:104811
. .6.
Hajishengallis
G
. Too old to fight? Aging and its toll on innate immunity
. Mol Oral Microbiol
. 2010 Feb
;25
(1
):25
–37
. .7.
Tay
MZ
, Poh
CM
, Rénia
L
, MacAry
PA
, Ng
LFP
. The trinity of COVID-19: immunity, inflammation and intervention
. Nat Rev Immunol
. 2020 Jun
;20
(6
):363
–37
.8.
Petrilli
CM
, Jones
SA
, Yang
J
, Rajagopalan
H
, O’Donnell
L
, Chernyak
Y
, et al. Factors associated with hospitalization and critical illness among 4,103 patients with Covid-19 disease in New York City
. medRxiv
. 2020
.9.
Song
CY
, Xu
J
, He
JQ
, Lu
YQ
. COVID-19 early warning score: a multi-parameter screening tool to identify highly suspected patients
. MedRxiv
. 2020 Jan 1
.10.
Wang
F
, Nie
J
, Wang
H
, Zhao
Q
, Xiong
Y
, Deng
L
, et al. Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia
. J Infect Dis
. 2020 May 11
;221
(11
):1762
–9
.11.
Yu
L
, Tong
Y
, Shen
G
, Fu
A
, Lai
Y
, Zhou
X
, et al. Immunodepletion with hypoxemia: a potential high risk subtype of coronavirus disease 2019
. medRxiv
. 2020 Jan 1
.12.
Zheng
M
, Gao
Y
, Wang
G
, Song
G
, Liu
S
, Sun
D
, et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients
. Cell Mol Immunol
. 2020 May
;17
(5
):533
–5
. .13.
Chu
H
, Chan
JF
, Wang
Y
, Yuen
TT
, Chai
Y
, Hou
Y
, et al. Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19
. Clin Infect Dis
. 2020 Sep 12
;71
(6
):1400
–9
. .14.
Liao
M
, Liu
Y
, Yuan
J
, Wen
Y
, Xu
G
, Zhao
J
, et al. The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencing
. medRxiv
. 2020 Jan 1
.15.
Wilk
AJ
, Rustagi
A
, Zhao
NQ
, Roque
J
, Martinez-Colon
GJ
, McKechnie
JL
, et al. A single-cell atlas of the peripheral immune response to severe COVID-19
. medRxiv
. 2020 Jan 1
.16.
17.
Gao
T
, Hu
M
, Zhang
X
, Li
H
, Zhu
L
, Liu
H
, et al. Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation
. medRxiv
. 2020 Jan 1
.18.
Grillet
F
, Behr
J
, Calame
P
, Aubry
S
, Delabrousse
E
. Acute pulmonary embolism associated with COVID-19 pneumonia detected by pulmonary CT angiography
. Radiology
. 2020 Sep
;296
(3
):E186
–8
.19.
Rotzinger
DC
, Beigelman-Aubry
C
, von Garnier
C
, Qanadli
SD
. Pulmonary embolism in patients with COVID-19: time to change the paradigm of computed tomography
. Thromb Res
. 2020 Apr 11
;190
:58
–9
. .20.
Campbell
CM
, Kahwash
R
. Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis?
Circulation
. 2020 Jun 2
;141
(22
):1739
–41
.21.
Risitano
AM
, Mastellos
DC
, Huber-Lang
M
, Yancopoulou
D
, Garlanda
C
, Ciceri
F
, et al. Complement as a target in COVID-19?
Nat Rev Immunol
. 2020 Jun
;20
(6
):343
–4
.22.
Long
QX
, Liu
BZ
, Deng
HJ
, Wu
GC
, Deng
K
, Chen
YK
, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19
. Nat Med
. 2020 Apr 29
.23.
Ju
B
, Zhang
Q
, Ge
X
, Wang
R
, Yu
J
, Shan
S
, et al. Potent human neutralizing antibodies elicited by SARS-CoV-2 infection
. BioRxiv
. 2020 Mar 21
:990770
.24.
Bao
L
, Deng
W
, Gao
, Xiao
C
, Liu
J
, Xue
J
, et al. Lack of reinfection in rhesus macaques infected with SARS-CoV-2
. bioRxiv
. 2020 May 01
.25.
Nie
S
, Zhao
X
, Zhao
K
, Zhang
Z
, Zhang
Z
, Zhang
Z
. Metabolic disturbances and inflammatory dysfunction predict severity of coronavirus disease 2019 (COVID-19): a retrospective study
. medRxiv
. 2020 Mar 24
:20042283
.26.
Wang
W
, He
J
, Wu
S
. The definition and risks of cytokine release syndrome-like in 11 COVID-19-infected pneumonia critically ill patients: disease characteristics and retrospective analysis
. Medrxiv
. 2020 Jan 1
.27.
Zheng
HY
, Zhang
M
, Yang
CX
, Zhang
N
, Wang
XC
, Yang
XP
, et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
. Cell Mol Immunol
. 2020 May
;17
(5
):541
–3
. .28.
Liu
B
, Han
J
, Cheng
X
, Yu
L
, Zhang
L
, Wang
W
, et al. Persistent SARS-CoV-2 presence is companied with defects in adaptive immune system in non-severe COVID-19 patients
. medRxiv
. 2020
. medRxiv 2020.03.26.20044768
.29.
Thevarajan
I
, Nguyen
THO
, Koutsakos
M
, Druce
J
, Caly
L
, van de Sandt
CE
, et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
. Nat Med
. 2020 Apr
;26
(4
):453
–5
. .30.
Duan
K
, Liu
B
, Li
C
, Zhang
H
, Yu
T
, Qu
J
, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients
. Proc Natl Acad Sci U S A
. 2020 Apr 28
;117
(17
):9490
–6
. .31.
Ni
L
, Ye
F
, Cheng
ML
, Feng
Y
, Deng
YQ
, Zhao
H
, et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals
. Immunity
. 2020 Jun 16
;52
(6
):971
–e3
. .32.
Verity
R
, Okell
LC
, Dorigatti
I
, Winskill
P
, Whittaker
C
, Imai
N
, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis
. Lancet Infect Dis
. 2020 Jun
;20
(6
):669
–77
.34.
Teo
JT
, Bean
D
, Bendeyan
R
, Dobson
R
, Shah
A
. Impact of ethnicity on outcome of severe COVID-19 infection. Data from an ethnically diverse UK tertiary centre
. medRxiv
. 2020 May 2
:2007864
.35.
Khunti
K
, Singh
AK
, Pareek
M
, Hanif
W
. Is ethnicity linked to incidence or outcomes of covid-19?
BMJ
. 2020 Apr 20
;369
:m1548
. .36.
Stefan
N
, Birkenfeld
AL
, Schulze
MB
, Ludwig
DS
. Obesity and impaired metabolic health in patients with COVID-19
. Nat Rev Endocrinol
. 2020 Apr 23
.37.
Stefan
N
, Häring
HU
, Schulze
MB
. Metabolically healthy obesity: the low-hanging fruit in obesity treatment?
Lancet Diabetes Endocrinol
. 2018 Mar
;6
(3
):249
–58
. .38.
Aparna
P
, Muthathal
S
, Nongkynrih
B
, Gupta
SK
. Vitamin D deficiency in India
. J Family Med Prim Care
. 2018 Mar–Apr
;7
(2
):324
–30
. .39.
Palacios
C
, Gonzalez
L
. Is vitamin D deficiency a major global public health problem?
J Steroid Biochem Mol Biol
. 2014 Oct
;144 Pt A
:138
–45
. 40.
Saul
L
, Mair
I
, Ivens
A
, Brown
P
, Samuel
K
, Campbell
JDM
, et al. 1,25-Dihydroxyvitamin D(3) restrains CD4(+) T cell priming ability of CD11c(+) dendritic cells by upregulating expression of CD31
. Front Immunol
. 2019 Mar 28
;10
:600
.41.
Venkatesh
HN
, Ravish
H
, Wilma Delphine Silvia
CR
, Srinivas
H
. Molecular signature of the immune response to yoga therapy in stress-related chronic disease conditions: an insight
. Int J Yoga
. 2020 Jan 1
;13
(1
):9
. .42.
Chen
J
, Ye
L
, Zhou
MY
, Cheng
YR
, Wang
MW
, Feng
ZH
. Herd immunity and COVID-19
. Eur Rev Med Pharmacol Sci
. 2020 Apr
;24
(8
):4064
–5
. .43.
Danchin
A
, Timmis
K
. SARS-CoV-2 variants: relevance for symptom granularity, epidemiology, immunity (herd, vaccines), virus origin and containment?
Environ Microbiol
. 2020 Jun
;22
(6
):2001
–6
.44.
Syal
K
. COVID-19: herd immunity and convalescent plasma transfer therapy
. J Med Virol
. 2020 Sep
;92
(9
):1380
–2
.45.
Kwok
KO
, Lai
F
, Wei
WI
, Wong
SYS
, Tang
JWT
. Herd immunity: estimating the level required to halt the COVID-19 epidemics in affected countries
. J Infect
. 2020 Jun
;80
(6
):e32
–3
.© 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
